Title : Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.

Pub. Date : 2021 Oct

PMID : 34052255






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LAY SUMMARY: Among patients receiving sorafenib for advanced hepatocellular carcinoma the rate of tumour growth (as assessed by changes in tumour size and the biomarker AFP) and the deterioration of liver function is less in those who have the Hepatitis C virus, than those who do not. Sorafenib alpha fetoprotein Homo sapiens